Integrin beta-2 (ITGB2 or CD18) Antibody - Western Blot Validated

About the Target

For consistent comparison across experiments, use this antibody to evaluate Integrin beta-2 (CD18) with a repeatable workflow. Integrin beta-2 is an extracellular or receptor-linked component that coordinates matrix engagement with cytoskeletal remodeling. For comparison-heavy studies, consistent sample handling and normalization help reduce run-to-run drift.

In some datasets and protocols, it is referenced by the gene symbol CD18.

Research Context

Because adhesion complexes are dynamic, timing and confluence can strongly influence measured signal. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

Consider these angles when interpreting target-level changes:

• remodeling after changes in substrate or mechanical stress
• focal adhesion versus diffuse membrane distribution
• co-variation with cytoskeletal and scaffold partners
• effects of adhesion inhibitors or matrix composition

Variant Considerations

When samples are prepared in reducing conditions, some epitopes become more accessible; this version is designed with that context in mind. This matters because epitope exposure and background can vary with preparation and extraction steps. Standardize key parameters so differences reflect biology rather than handling.

For challenging targets, pairing Integrin beta-2 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Integrin beta-2 patterns can be compared across experiments without guesswork.

With consistent handling, the denaturing-format format can make Integrin beta-2 (CD18) comparisons easier to reproduce across runs.